Webinars and Commercial Conversations — Register Now

Tuesday, December 1, 2026, 1 PM-2 PM ET

Join UCSF clinical microbiologists as they share their journey from using multiple respiratory testing platforms to implementing a flexible, stewardship-driven testing strategy. Learn how customizable respiratory panels helped streamline workflows, improve efficiency, and better align testing with patient needs.

Webinar presenters Danielle Ingebrigtsen, MHS, Clinical Laboratory Scientist Supervisor, UCSF Health, and Rama Yakubu, MD, PhD, Assistant Professor of Laboratory Medicine, Co-Director of Microbiology, UCSF Health.

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diasorin.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Wednesday, December 9, 2026, 12 PM-1 PM ET
Hear an expert pathologist discuss the role of HER2 IHC testing and scoring in solid tumors including endometrial, ovarian, cervical, bladder, non-small cell lung, colorectal, and biliary cancers

Webinar presenter Michelle Shiller, DO, MSPT, Baylor Sammons Cancer Center; Fulgent Genetics; Texas Cancer Interception Institute

CAP TODAY does not endorse any of the products or services named within. This program is intended for US healthcare professionals. This program is being sponsored by AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Tuesday, January 12, 2027, 2 PM-3 PM ET
Hear Dr. Roden discuss how computational pathology will impact the practice & future of precision oncology, using global real world analytical evidence for the novel TROP2 NMR biomarker as an example.

Webinar presenter Anja C. Roden, MD, Consultant, Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Professor of Laboratory Medicine and Pathology
Mayo Clinic College of Medicine and Science, Rochester, Minnesota

CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Roche Diagnostics. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Manage Subscription

To receive CAP TODAY magazine, please subscribe here.
For change of address, mail new information to: CAP TODAY Circulation, 325 Waukegan Road, Northfield, IL 60093-2750 or visit here.

September 2026

Molecular pathology selected abstracts

September 2026—HIV remains a major global public health concern, with an estimated 40.8 million people living with the virus in 2024. The challenge is particularly striking in low- and middle-income countries, where access to diagnostic testing may be limited. The World Health Organization’s universal test-and-treat strategy recommends that patients diagnosed with HIV immediately begin antiretroviral therapy regardless of their CD4 cell count or clinical stage. This strategy has placed greater emphasis on routine viral load monitoring, leading to a marked decline in CD4 testing and the discontinuation of many point-of-care CD4 platforms.

Q&A column

September 2026
Q. What is the percent acceptability when conducting a comparison test of activated clotting times (ACT)? Read answer.
Q. Is there any circumstance in which a manual bone marrow differential would be more accurate than flow cytometric analysis? Read answer.

Newsbytes

September 2026—Twelve U.S. health systems have joined forces with the clinical artificial intelligence company Aidoc to form the Diagnostic AI Consortium, with the goal of harnessing AI to improve the safety, quality, and speed of patient diagnosis and developing and adhering to standards for evaluating and governing the capability.

Put It on the Board

September 2026—A federal appeals court struck down portions of the federal regulations governing the calculation of the qualifying payment amount (QPA) under the No Surprises Act. The U.S. Court of Appeals for the Fifth Circuit, sitting en banc, issued its decision Aug. 11 in Texas Medical Association v. United States Department of Health and Human Services. The QPA is an insurer-calculated figure that is an important element in independent dispute resolution proceedings in which the amount an insurer owes to an out-of-network provider is adjudicated.